LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has ...
London, UK & Boston, MA, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the ...
Evaluate, a Norstella subsidiary, bought J+D Forecasting, a U.K.-based pharma forecasting solutions company, Wednesday morning. Terms of the deal were not disclosed, but Evaluate heralded J+D ...
LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate Ltd., the leading provider of commercial intelligence to the pharmaceutical industry, today released its latest data breakthrough, Product Specific ...
Managed Markets Insight & Technology, a provider of market access data, analytics and insights, and Evaluate, a provider of commercial intelligence and predictive analytics to the pharmaceutical ...
New capabilities greatly enhance Evaluate’s Competitive Intelligence Practice by combining best-in-class R&D, clinical and commercialisation intelligence with expert project, therapy area and ...
LONDON – [7 January 2026] – Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2026 Preview report, providing market forecasts for biopharma in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results